Rainer Wessel, PhD
Education/Work experience:
- Master’s Degree in Biology from the Universities of Münster and Heidelberg with focus on molecular biology, microbiology and biochemistr
- Master’s thesis in molecular biology at the Max-Planck-Institut for Medical Research in Heidelberg
- PhD in Molecular-, Cell- and Microbiology and Genetics from the University of Konstanz
- Patent consultant training at Boehringer Ingelheim
Expertise:
- Intellectual property, business strategy and management
- Organization, financing and management of technology ventures and clusters
- Oncology, infectology, immunology and biosecurity
- Research funding
- Lobbying
Management experience:
- 22 years of experience in R&D, intellectual property and management
- Various roles in international R&D and intellectual property at Boehringer Ingelheim (Osaka and Ingelheim)
- Head of IP & licensing at Qiagen
- Chairman of the Board of Axxima Pharmaceuticals AG and Ganymed Pharmaceuticals AG
- Manager of the Ci3 cluster
- Member of the Board of Directors of BIO Deutschland (winner of the “Organization of the Year” Innovation Award 2014)
General:
- English, basic Japanese
- “Language and Experience“ scholarship from the German Academic Exchange Service in Japan (Tokyo and Osaka)
- Member of the Development Board of the German Center for Cancer Research and the International Strategy Board of Oncotyrol
- Member of the Supervisory Board of the International Council for the Life Sciences (Washington)
- Member of the International Institute for Strategic Studies (London)
